BSOFT - BIRLASOFT LIMITED Share Price

In the earnings call held on January 28, 2026, Birlasoft's management provided an optimistic outlook, emphasizing their ability to maintain revenue and secure a solid order book despite a challenging demand environment. For Q3 FY26, the company reported a revenue of $150.8 million, reflecting a 0.3% growth in constant currency and a 0.1% increase in dollar terms.

Notably, the Total Contract Value (TCV) for Q3 reached $202 million, an impressive 89% surge quarter-on-quarter, with nearly half attributed to new engagements. Deal highlights included successful projects in the Manufacturing and BFSI sectors, focusing on AI and digital solutions. Management indicated an improved EBITDA margin of 18.2%, up 212 basis points from Q2, driven by better revenue quality and cost optimizations.

Forward-looking points include:

1. Management observed no major changes in the demand landscape, with customers concentrating on optimizing expenditures.
2. A cautious yet positive outlook was shared regarding potential revenue growth in Q4, primarily guided by increased deal signings.
3. Significant emphasis will be placed on enhancing the order booking pipeline and focusing on operational efficiencies.
4. Sectors such as BFSI and Energy & Utilities were deemed more stable, while Manufacturing was expected to face headwinds in the near term.
5. Management has signaled a commitment to invest in capabilities essential for long-term growth, maintaining a target steady-state EBITDA margin of around 15%.

Overall, while there are challenges, particularly in specific verticals, management expressed confidence in their growth strategy and operational execution for the coming quarters.

Below are the major questions and their respective answers from the Q&A section of the earnings transcript for Birlasoft Limited's Q3 FY26 earnings call:

Question 1: "If I look at the offshore revenue mix, it has jumped materially in this quarter. Is it fair to assume volume growth is materially higher versus the headline growth in constant currency terms?"

Answer: "Yes, your analysis is correct. We've deliberately shifted from staff augmentation to more outcome-based work. This has allowed us to enhance our offshore ratios, which indeed has led to higher volume growth, although it may suppress headline growth figures due to the offshore contribution. Overall, this strategy improves our margins."

Question 2: "Which vertical do you believe still carries some demand headwinds, and which vertical is giving you confidence for better growth?"

Answer: "While Manufacturing showed growth, I expect headwinds to continue in 4Q. Other verticals like E&U and Financial Services appear steadier. Manufacturing growth observed is more of a one-time revenue realization from prior deals rather than a sustainable trend. I anticipate a recovery starting in Q1 or Q2 of the next financial year for Manufacturing."

Question 3: "Can you provide a margin walk? Are we seeing significant one-offs influencing margins?"

Answer: "Certainly! Excluding one-offs seen, including around 110 basis points this quarter, our steady-state EBITDA margin would be around 16.5%. Expecting to invest for growth, we aim for 15% as sustainable margin moving forward. While we'll see some margins pressured due to pricing, our focus remains on operational efficiency."

Question 4: "Were furloughs similar this quarter to last year, or did we experience higher than usual furloughs?"

Answer: "Furloughs were in line with last year, around 0.5% to 1%. They are predictable seasonal factors on our revenue trajectory. Though impacted slightly, our expectations for Q4 are aligned with these anticipated trends, focusing on improving pipeline and signings."

Question 5: "What should we expect with a wage hike, and when will it be effective?"

Answer: "We've decided to implement a wage hike in the next financial year, with promotions coming this quarter. The hike timing will depend on levels within the organization but will fall between Q1 and Q2."

Question 6: "What is the situation in the Healthcare segment, given the current challenges?"

Answer: "While I'm bullish about our Life Sciences revenues, especially regarding med devices, healthcare pricing pressures remain due to existing tariff uncertainties. I anticipate this pressure will affect 4Q, but I don't expect volume degrowth."

Question 7: "Regarding cash flow and potential buybacks, what is the board's perspective?"

Answer: "The Board is actively considering capital allocation, which includes buybacks. It's essential for optimizing our balance sheet. We'll ensure that any decision made aligns strategically for future growth."

Question 8: "When you mention Q4 growth potential, why are your comments measured?"

Answer: "We remain cautiously optimistic. The growth observed in Manufacturing this quarter is not expected to continue into 4Q. Additionally, the reduced working days could suppress revenue. There's no specific growth percentage committed yet; we're focused on signings to enable future growth."

These responses summarize the core insights shared during the earnings call, capturing strategies and forward-looking statements while addressing current market conditions.